(a). A purchaser must make a copy of the original DEA Form 222 for its records and then submit the original to the supplier. The copy retained by the purchaser may be in paper or electronic form.

(b). A supplier may fill the order, if possible and if the supplier desires to do so, and must record on the original DEA Form 222 its DEA registration number and the number of commercial or bulk containers furnished on each item and the date on which the containers are shipped to the purchaser......

(a). A purchaser must make a copy of the original DEA Form 222 for its records and then submit the original to the supplier. The copy retained by the purchaser may be in paper or electronic form.

(b). A supplier may fill the order, if possible and if the supplier desires to do so, and must record on the original DEA Form 222 its DEA registration number and the number of commercial or bulk containers furnished on each item and the date on which the containers are shipped to the purchaser.

If an order cannot be filled in its entirety, it may be filled in part and the balance supplied by additional shipments within 60 days following the date of the DEA Form 222. No DEA Form 222 is valid more than 60 days after its execution by the purchaser, except as specified in paragraph (f) of this section.

(c). The controlled substances must be shipped only to the purchaser and the location printed by the Administration on the DEA Form 222, except as specified in paragraph (f) of this section.

(d). The supplier must retain the original DEA Form 222 for the supplier's files in accordance with §1305.17(c). Any supplier who is not required to report acquisition/disposition transactions to the Automation of Reports and Consolidated Orders System (ARCOS) under §1304.33(c) (such as a practitioner) must make and submit a copy of the original DEA Form 222 to DEA, either by mail to the Registration Section, or by email to [email protected].

The copy must be forwarded at the close of the month (not the close of next month) during which the order is filled. If an order is filled by partial shipments, the copy must be forwarded at the close of the month during which the final shipment is made or the 60-day validity period expires.

(e). The purchaser must record on its copy of the DEA Form 222 the number of commercial or bulk containers furnished on each item and the dates on which the containers are received by the purchaser.

(f). DEA Forms 222 submitted by registered procurement officers of the Defense Supply Center of the Defense Logistics Agency for delivery to armed services establishments within the United States may be shipped to locations other than the location printed on the DEA Form 222, and in partial shipments at different times not to exceed six months from the date of the order, as designated by the procurement officer when submitting the order.

PharmacyExam is proud to announce it first mobile application for studying NAPLEX through Naplex Audio Books and Naplex Flash Cards. Please download and review the app free by clicking appropriate below link.

For Google Play Store

https://play.google.com/store/apps/details?id=com.rxexam.naplex

For Itune App Store

https://itunes.apple.com/us/app/rxexam/id1448199697?ls=1&mt=8

We hope you like it.

Pharmacy Exam

PharmacyExam is proud to announce it first mobile application for studying NAPLEX through Naplex Audio Books and Naplex Flash Cards. Please download and review the app free by clicking appropriate below link.

For Google Play Store

https://play.google.com/store/apps/details?id=com.rxexam.naplex

For Itune App Store

https://itunes.apple.com/us/app/rxexam/id1448199697?ls=1&mt=8

We hope you like it.

Pharmacy Exam

We have recently created new product for letting students familiar with Biostatistics.

Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/185/naplex---biostatistics.cfm

You can also view sample questions related to this product by visiting following link:

https://www.pharmacyexam.com/images/pdf/Biostatistics_Sample_Questions.pdf

Pharmacy Exam

We have recently created new product for letting students familiar with Biostatistics.

Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/185/naplex---biostatistics.cfm

You can also view sample questions related to this product by visiting following link:

https://www.pharmacyexam.com/images/pdf/Biostatistics_Sample_Questions.pdf

Pharmacy Exam

We have recently created new product for letting students familiar with sterile compounding and hazardous drugs. Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/183/sterile-compounding--hazardous-drugs.cfm

You can also view sample questions related to this product by visiting following link:

https://www.pharmacyexam.com/index.cfm?fuseaction=category.display&category_id=184

Pharmacy Exam

We have recently created new product for letting students familiar with sterile compounding and hazardous drugs. Below is the link for product information.

https://www.pharmacyexam.com/index.cfm/category/183/sterile-compounding--hazardous-drugs.cfm

You can also view sample questions related to this product by visiting following link:

https://www.pharmacyexam.com/index.cfm?fuseaction=category.display&category_id=184

Pharmacy Exam

The 2016 CDC guideline for prescribing opioids suggests to reassess the evidence of “individual benefit and risk” when increasing daily dose to above ____ morphine milligrams equivalent per day.
  
a. 30
b. 50
c. 90
d. 120

The 2016 CDC guideline for prescribing opioids suggests to reassess the evidence of “individual benefit and risk” when increasing daily dose to above ____ morphine milligrams equivalent per day.
  
a. 30
b. 50
c. 90
d. 120

Answer(b): The 2016 CDC guideline for prescribing opioids suggests to reassess the evidence of “individual benefit and risk” when increasing daily dose to above 50 morphine milligrams equivalent per day, and avoidance of doses greater than 90 MME per day.

Which of the following are administered by Centers for Medicare & Medicaid Services (CMS)? [Select ALL That Apply]
 
a. Medicare
b. Medicaid
c. Clinical Laboratory Improvement Amendments (CLIA)
d. Children's Health Insurance Program (CHIP)

Which of the following are administered by Centers for Medicare & Medicaid Services (CMS)? [Select ALL That Apply]
 
a. Medicare
b. Medicaid
c. Clinical Laboratory Improvement Amendments (CLIA)
d. Children's Health Insurance Program (CHIP)

Answer (a, b, c and d). The Centers for Medicare & Medicaid Services (CMS), a component of the Department of Health and Human Services (HHS), administers Medicare, Medicaid, the Children's Health Insurance Program (CHIP), the Clinical Laboratory Improvement Amendments (CLIA) and parts of the Affordable Care Act (ACA.
 
Along with the Departments of Labor and Treasury, CMS also implements the insurance reform provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and most aspects of the Patient Protection and Affordable Care Act (PPACA) of 2010 as amended.
 
The Social Security Administration is responsible for determining Medicare eligibility, eligibility for and payment of Extra Help/Low Income Subsidy payments related to Part D Medicare, and collecting some premium payments for the Medicare program.

Illegal Purchases of Controlled Substances Are Made Easier via Rogue Internet Drug Outlets, Reports NABP.

Last week, NABP released its Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: July 2016. The report explores the connection between the dangers of rogue internet drug outlets and the risk of overdose from illegally dispensed prescription controlled substances (CS), as well as possibly tainted counterfeit medicines.
 
Over the past eight years, NABP has worked to identify illegally operating websites to keep consumers safe and to try to decrease the overdoses and fatalities related to prescription drug misuse and abuse. Currently, 11,299 online drug outlets that sell prescription medications have been reviewed by NABP, and 95.79% have been classified as Not Recommended given that the websites are selling prescription medications out of compliance with state and federal laws and/or Association patient safety and pharmacy practice standards.
 
For the full report, visit the Not Recommended Online Pharmacies page in the Acquire Safely section of the AWARXE® Prescription Drug Safety website. You can avoid rogue internet drug outlets by buying from websites with a .pharmacy domain name. To see the list of approved entities with registered .pharmacy domain names, visit the Buying Safely section at www.safe.pharmacy. 

Pharmacists were rated as the most trusted health care providers, according to a new consumer health survey. The results of the survey show that 60% of consumers trust pharmacists, 56% trust doctors, and 51% trust dentists. The Meyocks Health Survey reports that consumers trust the people who directly provide health care more than others in the health care system. Pharmacists had the highest trust rate and the lowest distrust rate among other groups in the survey, notes Drug Store News.

Pharmacists were rated as the most trusted health care providers, according to a new consumer health survey. The results of the survey show that 60% of consumers trust pharmacists, 56% trust doctors, and 51% trust dentists. The Meyocks Health Survey reports that consumers trust the people who directly provide health care more than others in the health care system. Pharmacists had the highest trust rate and the lowest distrust rate among other groups in the survey, notes Drug Store News.

North Carolina and Texas Sign Legislation to Make Naloxone More Accessible to Patients

New legislation in North Carolina and Texas make naloxone, the opioid overdose reversal drug, more accessible to patients. North Carolina Governor Pat McCrory signed Senate Bill (SB) 734 into law on June 20, 2016, which authorizes the state health director to prescribe an opioid antagonist using a statewide standing order.

Under the former law, only a practitioner was authorized to prescribe an opioid antagonist pursuant to a standing order. SB 734 became effective the same day, according to the North Carolina Health and Human Services press release.
 
Beginning August 1, 2016, pharmacists in Texas will be authorized to dispense naloxone to patients under a standing order. The legislation will require pharmacists to complete a one-hour course accredited by the Accreditation Council for Pharmacy Education and in coordination with the Texas Pharmacy Association, according to a press release.

SB 1462 states an authorized prescriber may prescribe an opioid antagonist through a standing order. Medical doctors have unlimited, independent prescribing authority in every state. NABP’s 2016 Survey of Pharmacy Law states that pharmacists in Texas may perform specific acts relating to drug therapy management under written protocol from a practitioner including implementing or modifying therapy.